Location History:
- Gauting-Unterbrunn, DE (2007 - 2019)
- Gauting, DE (2013 - 2020)
Company Filing History:
5 out of 48 
2 out of 119 
1 out of 36 
Years Active: 2007-2020
Title: Ulrich Moebius: Innovator in Cancer Treatment
Introduction
Ulrich Moebius is a notable inventor based in Gauting-Unterbrunn, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for cancer and viral diseases. With a total of 7 patents to his name, his work continues to impact the medical community.
Latest Patents
One of his latest patents is an anti-cancer fusion polypeptide. This invention provides a fusion polypeptide that is specific for both CD137 and HER2/neu. This fusion polypeptide can be utilized for directing CD137 clustering and activation to HER2/neu-positive tumor cells. It has potential applications as anti-cancer agents and immune modulators for treating or preventing various human diseases, including tumors. The patent also covers methods for creating the fusion polypeptide and compositions that include it. Another significant patent involves a medicament for treating viral skin and tumor diseases. This invention includes a compound of a specific general formula that serves as a therapeutically active agent, either alone or in combination with other pharmaceutical agents. It is particularly aimed at treating diseases caused by human papilloma virus (HPV) and herpes viruses.
Career Highlights
Throughout his career, Ulrich Moebius has worked with prominent organizations such as Medigene AG and the German Cancer Research Center (Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts). His work in these institutions has allowed him to advance his research and contribute to significant medical innovations.
Collaborations
Some of his notable coworkers include Yunik Chang and Robert Lathrop. Their collaborative efforts have further enhanced the impact of his inventions in the medical field.
Conclusion
Ulrich Moebius is a distinguished inventor whose work in cancer treatment and viral disease management has led to several important patents. His contributions continue to shape the future of pharmaceuticals and improve patient outcomes.